Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ANGO - AngioDynamics on go to start NanoKnife DIRECT clinical study

ANGO - AngioDynamics on go to start NanoKnife DIRECT clinical study

AngioDynamics Inc.
  • The FDA approves AngioDynamics' (NASDAQ:ANGO) investigational device exemption (IDE) application for NanoKnife Irreversible Electroporation “Direct IRE Cancer Treatment” clinical study ((DIRECT)).
  • More news on: AngioDynamics, Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: AngioDynamics Inc.
Stock Symbol: ANGO
Market: NASDAQ
Website: angiodynamics.com
Menu
ANGO ANGO Quote ANGO Short ANGO News ANGO Articles ANGO Message Board
Get ANGO Alerts

News, Short Squeeze, Breakout and More Instantly...